Apnimed, Inc. (APMD) Financials
APMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 342.6 million | 85.0 million |
| March 31, 2025 | ? | ? |
APMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -19.8 million | 929000 |
| March 31, 2025 | -28.5 million | 802000 |
APMD Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 70.4 million |
| March 31, 2025 | -28.6 million |
APMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | - | - | 812000 |
| March 31, 2025 | - | - | - |
APMD Shares Outstanding
APMD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 8.1 million | 6.5 million | - |
| March 31, 2025 | - | 23.5 million | 5.5 million | - |
APMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 84.8 million | 2.2 million |
| March 31, 2025 | 3.1 million | 1.3 million |
APMD
Price: $17.64
52 week price:
Earnings Per Share: 2.43 USD
P/E Ratio: 11.30
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 866.2 million